ScreenerHero

VEXT Vext Science Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · vextscience.com
0.2250CAD0.00%Mkt Cap: 40.59M $P/E: —

Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultiva…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
$57.06BUSD
TEVA
Teva Pharmaceutical Industries Limited Ordinary Shares
$46.10BUSDP/E 65.9
HLN
Haleon plc American Depositary Shares (Each representing two Ordinary Shares)
$38.70BUSDP/E 18.3
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
ZTS
Zoetis Inc. Class A Common Stock
$28.80BUSDP/E 11.4
UTHR
United Therapeutics Corporation - Common Stock
$23.23BUSDP/E 19.4
VTRS
Viatris Inc. - Common Stock
$20.22BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc. - Common Stock
$14.55BUSDP/E 21.0
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated Common Stock
$11.06BUSD
RDY
Dr. Reddy's Laboratories Ltd Common Stock
$10.20BUSDP/E 29.2
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
AMRX
Amneal Pharmaceuticals, Inc. - Class A Common Stock
$7.07BUSDP/E 42.3
ALKS
Alkermes plc - Ordinary Shares
$7.00BUSDP/E 109.9
HIMS
Hims & Hers Health, Inc. Class A Common Stock
$6.77BUSD
LNTH
Lantheus Holdings, Inc. - Common Stock
$6.53BUSDP/E 23.9
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
$5.83BUSDP/E 76.6
INDV
Indivior Pharmaceuticals, Inc. - Common Stock
$4.21BUSDP/E 12.8

Key Statistics

Company
Market Cap40.59M USD
Enterprise Value61.88M USD
Revenue (TTM)36.91M USD
Gross Profit10.53M USD
Net Income (TTM)-13.10M USD
Revenue/Share0.20 CAD
Last Price0.2250 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA9255401064
Valuation
P/E (Trailing)—
P/E (Forward)-5.63
PEG—
EV/EBITDA7.79
EV/Revenue1.68
P/S1.10
P/B0.74
EPS (TTM)-0.08
EPS (Forward)-0.04
52W Range
0.190017% of range0.4000
52W High0.4000 CAD
52W Low0.1900 CAD
Profitability
Gross Margin28.14%
Oper. Margin6.51%
EBITDA Margin21.53%
Profit Margin-35.03%
ROE-32.50%
ROA-14.93%
Growth
Revenue Growth-9.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF8.53M USD
CapEx (TTM)2.60M USD
FCF Margin3.82%
FCF Yield3.48%
Net Debt21.29M USD
Net Debt/EBITDA2.68
Balance Sheet
Debt/Equity0.63
Current Ratio0.97
Quick Ratio0.19
Book Value/Sh0.30 CAD
Cash/Share0.02 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 CAD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)0.9500 CAD
Upside (mean)+322.2%
Target Range0.9500 CAD – 0.9500 CAD
# Analysts1
Ownership
Shares Out.185.82M
Float101.67M
Insiders45.69%
Institutions0.35%
Short Interest
Short Ratio0.3d
Short % Out.0.01%
Shares Short32.20K
Short (prev mo.)559
Technical
SMA 500.2604 (-13.6%)
SMA 2000.2646 (-15.0%)
Beta0.81
S&P 52W Chg14.58%
Avg Vol (30d)40.71K
Avg Vol (10d)75.73K
Technical Indicators
RSI (14)38.7
MACD-0.0043
MACD Signal-0.0017
MACD Hist.-0.0026
BB Upper0.2642 CAD
BB Middle0.2437 CAD
BB Lower0.2233 CAD
BB Width16.81%
ATR (14)0.0105 CAD
Vol Ratio (20d)3.35x